Stockscreener 앱 받기
0.701
1.59%
0.011
시간 외 거래:
1.96
1.259
+179.60%
Neuroone Medical Technologies Corp 주식(NMTC)의 최신 뉴스
Certain Warrants of NeuroOne Medical Technologies Corporation are subject to a Lock-Up Agreement Ending on 19-JUN-2025. - MarketScreener
Jane Street Group LLC Takes $33,000 Position in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Medical (NMTC) Enhances Leadership with New General Cou - GuruFocus
NeuroOne Cuts Legal Costs with Strategic General Counsel Hire: Former Partner Joins Executive Team - Stock Titan
NeuroOne CEO to Meet Investors at MedInvest Conference: Spotlight on Neural Surgery Innovation - Stock Titan
NeuroOne Medical Technologies (NASDAQ:NMTC) Trading 1.1% Higher – Should You Buy? - Defense World
NeuroOne Completes FDA Submission for OneRF Trigeminal Nerve Ablation System - Medical Product Outsourcing
NeuroOne Medical Technologies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
NMTC Achieves Growth in Q2 with Advancements in OneRF Technology - GuruFocus
Earnings call transcript: NeuroOne Medical beats EPS expectations in Q1 2025 - Investing.com Canada
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call - GuruFocus
NeuroOne Medical Technologies Corp Reports Q2 FY2025 Earnings: E - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp SEC 10-Q Report - TradingView
NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% - Stock Titan
NeuroOne Medical (NMTC) Welcomes New Chief Medical Advisor | NMT - GuruFocus
NeuroOne Medical Technologies (NMTC) Appoints New Chief Medical Advisor - GuruFocus
NeuroOne appoints Dr. Patil as Chief Medical Advisor - Investing.com
NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor - Stock Titan
NeuroOne Medical Opens Exclusive Investor Access: CFO Hosts One-on-One Meetings at Plaza Hotel - Stock Titan
NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
NeuroOne Medical Tech (NMTC) Coverage Initiated by Ladenburg Tha - GuruFocus
This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Geode Capital Management LLC Grows Stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) - Defense World
NeuroOne Earnings: Medical Tech Leader to Reveal Q2 2025 Growth Strategy and Financial Results - Stock Titan
NeuroOne Medical Technologies Corp [NMTC] Records 50-Day SMA of $0.8911 - knoxdaily.com
NeuroOne Medical Technologies Corp’s results are impressive - uspostnews.com
The Future of NeuroOne Medical Technologies Corp: Analyzing NMTC - investchronicle.com
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigemina - GuruFocus
NeuroOne Medical (NMTC) Files Early FDA Submission for Trigeminal Nerve Ablation | NMTC Stock News - GuruFocus
NeuroOne files early FDA 510(k) for nerve ablation system - Investing.com
NeuroOne's Revolutionary Facial Pain Treatment Advances: FDA Review Next for 95% Effective Device - Stock Titan
EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain - Benzinga
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call Highlights: Regulatory Success ... - Yahoo Finance
NeuroOne Medical Technologies Corp (NMTC) Q1 2025 Earnings Call - GuruFocus
CTEK Expects Significant Revenue Growth by Fiscal Year 2025 | NMTC Stock News - GuruFocus
NeuroOne Medical (NMTC) Expands Partnership with Zimmer Biomet and Secures Funding | NMTC Stock News - GuruFocus
Neuroone Medical Technologies Corp -Company Now Fully Funded Through At Least Fiscal 2026 - marketscreener.com
NeuroOne secures funding through fiscal 2026, unaffected by tariffs - Investing.com
NeuroOne Secures $11.3M in Fresh Capital, Forecasts Triple-Digit Growth - Stock Titan
NeuroOne Medical (NMTC) Gains Attention with Successful Pediatric Epilepsy Treatment | NMTC Stock News - GuruFocus
Breakthrough: Teen Goes from 10 Seizures Per Night to Zero with New Brain Treatment - Stock Titan
Teen goes from 10 nightly seizures to zero with brain implant - Fox News
Ronald McClurg Spends US$100k On NeuroOne Medical Technologies Stock - Yahoo
NeuroOne Medical Technologies CEO buys $50,000 in common stock By Investing.com - Investing.com India
NeuroOne Medical Technologies CEO buys $50,000 in common stock - Investing.com Australia
NeuroOne Medical’s CFO Ronald McClurg buys $100,000 in stock By Investing.com - Investing.com South Africa
NeuroOne Medical's CFO Ronald McClurg buys $100,000 in stock - Investing.com
NeuroOne Executives Make Significant Stock Purchases - TradingView
0.19%
자본화:
|
볼륨(24시간):